The expression of Cx32 was down-regulated in preneoplastic and HCC lesions in rats [19], and gradually decreased during progression of chronic liver disease including viral hepatitis, cirrhosis and HCC in humans [20, 21]. This evidence concerns the gene GJB1 and hepatocellular carcinoma.